The Relationship Between Insulin Resistance and Cancer in Humans
Hormone and Metabolic Research · 01.10.2025 · 57 (10) · 539-556
DOI: 10.1055/a-2715-0775 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.10.2025. Verfasst von María M Adeva-Andany und 5 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Hospital Juan Cardona, Ferrol, Spain. Hauptthemen laut MEDLINE: Insulin Resistance, Neoplasms. Die Arbeit nennt 255 Literaturangaben.
Abstract (Originalsprache)
An independent association between insulin resistance and cancer has been consistently reported in humans. Patients with cancer display insulin resistance or its clinical manifestations, and this metabolic adaptation precedes the clinical diagnosis of cancer. Insulin resistance in cancer patients is associated with a metabolic switch from oxidative metabolism toward glycolysis that spares oxygen to be used in anabolic processes and facilitates the fast production of energy and intermediate metabolites required for the rapid proliferation of cancer cells. In malignant cells, glucose consumption via glycolysis occurs under normoxic conditions (aerobic glycolysis). Pathogenic mechanisms underlying insulin resistance in cancer patients include hypoxia-inducible factor-1 upregulation and overproduction of cytokines, such as interferon, interleukin-6, interleukin-18, and interleukin-1β. Deficit of 2-oxoglutarate (α-ketoglutarate) has been detected in cancer cells and may facilitate hypoxia-inducible factor-1 assembly and activity. Overproduction of cytokines in cancer patients follows activation of the immune system by abnormal nucleic acid variants. Anomalous DNA or RNA structures are recognized by immune sensors and stimulate signaling pathways that ultimately increase cytokine production. Likewise, interferon overproduction occurs in congenital disorders that feature ineffectively repaired DNA lesions, such as Werner syndrome, Bloom syndrome, mutations in DNA polymerase-δ1, and ataxia telangiectasia. These diseases cause simultaneous insulin resistance and a high tendency to develop cancer, highlighting the relationship between the two processes. Defectively repaired DNA injury endangers genomic integrity, predisposing to cancer, and activates the immune system to increase interferon production and subsequent insulin resistance. Hypoxia-inducible factor-1 and cytokines induce insulin resistance by suppressing peroxisome proliferator-activated-γ in the subcutaneous adipose tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Internal Medicine, Hospital Juan Cardona, Ferrol, Spain.
- Internal Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain.
Zitieren
APA
Adeva-Andany, M. M., Adeva-Contreras, L., Ameneiros-Rodriguez, E., Carneiro-Freire, N., Vila-Altesor, M., & Funcasta-Calderon, R. (2025). The Relationship Between Insulin Resistance and Cancer in Humans. Hormone and Metabolic Research, 57(10), 539-556. https://doi.org/10.1055/a-2715-0775
Vancouver
Adeva-Andany MM, Adeva-Contreras L, Ameneiros-Rodriguez E, Carneiro-Freire N, Vila-Altesor M, Funcasta-Calderon R. The Relationship Between Insulin Resistance and Cancer in Humans. Hormone and Metabolic Research. 2025;57(10):539-556. doi:10.1055/a-2715-0775
BibTeX
@article{AdevaAndany2025,
author = {Adeva-Andany, María M and Adeva-Contreras, Lucia and Ameneiros-Rodriguez, Eva and Carneiro-Freire, Natalia and Vila-Altesor, Matilde and Funcasta-Calderon, Raquel},
title = {The Relationship Between Insulin Resistance and Cancer in Humans},
journal = {Hormone and Metabolic Research},
year = {2025},
volume = {57},
number = {10},
pages = {539--556},
doi = {10.1055/a-2715-0775}
}
EUVIMED